CME and CFTC Clash Over On-Chain Perpetual Futures

The ongoing dispute between the CME Group and the Commodity Futures Trading Commission (CFTC) has sparked a heated debate over the regulation of on-chain perpetual futures. The CFTC recently approved the listing of crypto perps, decentralized derivative contracts that allow users to speculate on the price of an asset with leverage and no expiration date, by the prediction markets platform Kalshi and cryptocurrency exchange Coinbase. However, the CME has challenged this decision, arguing that the products are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the ramifications. The CME claims that the agency is mislabeling the products and therefore misapplying the law, as futures need an end date. The lawsuit argues that these perps are designed for traders to take a financial position on an asset's future without any deadlines, which is not in line with the traditional definition of futures. The tension between the two entities has been escalating, with the CME attempting to fast-track 24/7 trading for crude oil futures, only to be blocked by the CFTC. The CFTC's decision to allow blockchain-based perpetual futures products has been seen as a significant development in the rapidly growing arena, with non-US perps volume reportedly growing to $60 trillion in volume last year. The outcome of this dispute could have significant implications for the US approach to regulating on-chain perpetual futures, with many experts weighing in on the issue. Jake Chervinsky, CEO of the Hyperliquid Policy Center, noted that it is unusual to see the largest exchange in America attacking its own regulator, and that the CME's stance is typical of the way large incumbents handle innovation that might threaten their dominance. Terry Duffy, chairman of the CME, has been vocal about his opposition to the CFTC's decision, arguing that the agency did not follow the proper protocol and that the products are not properly regulated. The CFTC's chairman, Mike Selig, has defended the agency's decision, stating that the CME's decision to disregard the Commission's effort to undertake a reasoned analysis of the critical issues at stake is wholly inappropriate. The dispute is ongoing, with the CME preparing its case and the CFTC standing by its decision. The outcome will likely have significant implications for the future of on-chain perpetual futures in the US.